Protection against oxidant-mediated lysosomal rupture: a new anti-apoptotic activity of Bcl-2?

被引:81
|
作者
Zhao, M
Eaton, JW
Brunk, UT [1 ]
机构
[1] Linkoping Univ, Fac Hlth Sci, Div Pathol 2, SE-58185 Linkoping, Sweden
[2] Univ Louisville, James Graham Brown Canc Ctr, Louisville, KY 40202 USA
关键词
lysosome stability; Bcl-2; oxidative stress; apoptosis;
D O I
10.1016/S0014-5793(00)02195-5
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Bcl-2 antagonizes apoptosis through mechanisms which are not completely understood. We have proposed that apoptosis is initiated by minor lysosomal destabilization followed some time later by secondary massive lysosomal rupture. In J774 cells over-expressing Bcl-2, early oxidant-induced lysosomal destabilization is unaffected but secondary lysosomal rupture and apoptosis are suppressed, despite the fact that wild-type and Bcl-2 over-expressing cells degrade hydrogen peroxide at similar rates. It may be that Bcl-2 directly blocks the effects of released lysosomal enzymes and/or prevents downstream activation of unknown cytosolic pro-enzymes by released lysosomal hydrolases, suggesting a new and heretofore unknown activity of Bcl-2, (C) 2000 Federation of European Biochemical Societies. Published by Elsevier Science B.V. All rights reserved.
引用
收藏
页码:104 / 108
页数:5
相关论文
共 50 条
  • [21] Antisense bcl-2 transfection up-regulates anti-apoptotic and anti-oxidant thioredoxin in neuroblastoma cells
    Li, YT
    Lu, ZH
    Chen, F
    Guan, J
    Hu, LP
    Xu, YF
    Chen, J
    JOURNAL OF NEURO-ONCOLOGY, 2005, 72 (01) : 17 - 23
  • [22] The anti-apoptotic Bcl-2 protein regulates hair follicle stem cell function
    Geueke, Anna
    Mantellato, Giada
    Kuester, Florian
    Schettina, Peter
    Nelles, Melanie
    Seeger, Jens Michael
    Kashkar, Hamid
    Niemann, Catherin
    EMBO REPORTS, 2021, 22 (10)
  • [23] Bcl-2 complexed with Beclin-1 maintains full anti-apoptotic function
    Ciechomska, I. A.
    Goemans, G. C.
    Skepper, J. N.
    Tolkovsky, A. M.
    ONCOGENE, 2009, 28 (21) : 2128 - 2141
  • [24] Bcl-2 complexed with Beclin-1 maintains full anti-apoptotic function
    I A Ciechomska
    G C Goemans
    J N Skepper
    A M Tolkovsky
    Oncogene, 2009, 28 : 2128 - 2141
  • [25] Role of Anti-apoptotic Activity of Antioxidants in Conferring Protection Against Prostate Cancer
    Chen, Peijie
    Bai, Peiming
    Luo, Guangcheng
    Su, Hanzhong
    Shen, Ruixiong
    Liu, Ziming
    Zhang, Nangen
    Fang, Lin
    Liu, Chunxiao
    INTERNATIONAL JOURNAL OF PHARMACOLOGY, 2016, 12 (04) : 304 - 316
  • [26] Current overview on the clinical update of Bcl-2 anti-apoptotic inhibitors for cancer therapy
    Suvarna, Vasanti
    Singh, Vikas
    Murahari, Manikanta
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2019, 862
  • [27] Loss of anti-mitotic effects of Bcl-2 with retention of anti-apoptotic activity during tumor progression in a mouse model
    Priscilla A Furth
    Ud Bar-Peled
    Minglin Li
    Albert Lewis
    Rodolfo Laucirica
    Richard Jäger
    Hans Weiher
    Robert G Russell
    Oncogene, 1999, 18 : 6589 - 6596
  • [28] Rapamycin increases the cellular concentration of the BCL-2 protein and exerts an anti-apoptotic effect
    Calastretti, A
    Rancati, F
    Ceriani, MC
    Asnaghi, L
    Canti, G
    Nicolin, A
    EUROPEAN JOURNAL OF CANCER, 2001, 37 (16) : 2121 - 2128
  • [29] Loss of anti-mitotic effects of Bcl-2 with retention of anti-apoptotic activity during tumor progression in a mouse model
    Furth, PA
    Bar-Peled, U
    Li, ML
    Lewis, A
    Laucirica, R
    Jäger, R
    Weiher, H
    Russell, RG
    ONCOGENE, 1999, 18 (47) : 6589 - 6596
  • [30] Mechanism of apoptosis induction by inhibition of the anti-apoptotic BCL-2 proteins
    Chipuk, Jerry E.
    Fisher, John C.
    Dillon, Christopher P.
    Kriwacki, Richard W.
    Kuwana, Tomomi
    Green, Douglas R.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2008, 105 (51) : 20327 - 20332